D&D Pharmatech디앤디파마텍
347850 · KOSDAQ · ₩347850 · 디앤디파마텍
₩42,900▲ ₩2,100 (5.15%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | −1,367.9% | −791.0% | −218.7% |
| Net margin | −785.5% | −548.1% | −250.3% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | −36.0% | −62.4% | — |
| Operating income growth | −10.7% | −35.9% | — |
| Net income growth | +8.3% | +17.7% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | −20.2% | −31.5% | −40.8% |
| Return on assets | −10.4% | −24.6% | −30.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 138.6% | 23.5% | 40.1% |
| Net debt to equity | −31.8% | −41.6% | −40.5% |
| Current ratio | 2,720.7% | 941.0% | 358.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: D&D Pharmatech / 디앤디파마텍 / 347850 / KRX:347850
Source: KRX statistical information